Gynesonics’ Sonata System 2.1 Gets Green Light | 2020-06-01 | FDAnews

Gynesonics’ Sonata System 2.1 Gets Green Light | 2020-06-01 | FDAnews

Gynesonics’ Sonata System 2.1

Gynesonics has earned 510(k) clearance from the FDA for its next-generation Sonata System 2.1 for ablating symptomatic uterine fibroids. The platform combines ultrasound with an advanced radio-frequency ablation device, allowing for incisionless, transcervical treatment of fibroids in the uterus.

Sourced through Scoop.it from: www.fdanews.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *